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BACKGROUND: Household air pollution due to biomass combustion for residential heating adversely aﬀects vulnerable populations. Randomized controlled trials to improve indoor air quality in homes of children with asthma are limited, and no such studies have been conducted in homes using
wood for heating.
OBJECTIVES: Our aims were to test the hypothesis that household-level interventions, speciﬁcally improved-technology wood-burning appliances or
air-ﬁltration devices, would improve health measures, in particular Pediatric Asthma Quality of Life Questionnaire (PAQLQ) scores, relative to placebo, among children living with asthma in homes with wood-burning stoves.
METHODS: A three-arm placebo-controlled randomized trial was conducted in homes with wood-burning stoves among children with asthma.
Multiple preintervention and postintervention data included PAQLQ (primary outcome), peak expiratory ﬂow (PEF) monitoring, diurnal peak ﬂow
variability (dPFV, an indicator of airway hyperreactivity) and indoor particulate matter (PM) PM2:5 .
RESULTS: Relative to placebo, neither the air ﬁlter nor the woodstove intervention showed improvement in quality-of-life measures. Among the secondary outcomes, dPFV showed a 4.1 percentage point decrease in variability [95% confidence interval ðCIÞ = − 7:8 to −0:4] for air-ﬁltration use in
comparison with placebo. The air-ﬁlter intervention showed a 67% (95% CI: 50% to 77%) reduction in indoor PM2:5 , but no change was observed
with the improved-technology woodstove intervention.
CONCLUSIONS: Among children with asthma and chronic exposure to woodsmoke, an air-ﬁlter intervention that improved indoor air quality did not
aﬀect quality-of-life measures. Intent-to-treat analysis did show an improvement in the secondary measure of dPFV.
Trial registration: ClincialTrials.gov NCT00807183. https://doi.org/10.1289/EHP849

Introduction
Several studies of children with asthma in urban environments
have targeted the household environment to improve health outcomes (Bryant-Stephens 2009; Butz et al. 2011; Eggleston et al.
2005; Krieger et al. 2005; Levy et al. 2006; Morgan et al. 2004;
Sweet et al. 2014). These intervention studies have targeted asthma
triggers by employing education strategies and/or directly mitigating
exposure to allergens through pest management and/or use of
allergen-impermeable mattress and pillow encasings. Three of these
studies incorporated air-ﬁlter devices in the intervention strategy to
reduce children’s exposure to airborne allergens, dust, or environmental tobacco smoke (Butz et al. 2011; Eggleston et al. 2005;
Morgan et al. 2004). The intervention strategies consistently demonstrated declines in asthma-related symptom measures. However, all
of these studies were conducted in urban environments, and the nature of these exposures likely diﬀer from that of exposures in rural
environments.
Attention to home heating sources in asthma intervention trials
has been limited. One randomized trial showed lower frequency of
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asthma symptoms and health care visits compared with controls
when improved heating-source interventions were employed to
increase indoor temperature and decrease NO2 concentrations
(Howden-Chapman et al. 2008). To our knowledge, no randomized
controlled trials among children with asthma have been conducted
that target indoor particulate matter (PM) exposures in rural-area
homes heated by residential woodstoves.
Biomass combustion is known to be an important contributor
to household air pollution in developing countries with resultant
adverse health eﬀects (Smith et al. 2014). The exposure scenarios
and health consequences related to biomass combustion in
developing-country settings are distinct from those in highincome countries. Nevertheless, burning wood for residential
heating is an important PM exposure source in many developed
countries, particularly in rural settings. The U.S. Department of
Energy estimates that there are 11:6 million homes that use wood
as a primary or secondary heating fuel (U.S. Department of
Energy 2009), translating to more than three million children living in woodstove-heated homes (Noonan et al. 2015). Estimates
of the contribution of wood-burning to ambient air quality can
vary widely (Naeher et al. 2007), but woodsmoke accounts for
80– 90% of the ambient PM concentrations in communities with
a high proportion of wood-burning households (Johnston et al.
2013; McGowan et al. 2002; Ward and Lange 2010; Ward et al.
2006). In the European Union, it is estimated that domestic
woodstoves will be the dominant source of ambient ﬁne PM
(PM2:5 ), accounting for 38% of all emissions by 2020 (Sigsgaard
et al. 2015).
Indoor PM2:5 concentrations in homes that heat with wood often exceed the World Health Organization daily ambient airquality standard of 25 lg=m3 (Noonan et al. 2012; Semmens
et al. 2015; Ward et al. 2011), likely the result of indoor PM sources and inﬁltration of ambient PM from local sources (Allen
et al. 2003; Barn et al. 2008; Hystad et al. 2009; Semmens et al.
2015). Few exposure-reduction interventions have been tested in
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such wood-burning households (Allen et al. 2011; Noonan et al.
2012; Ward et al. 2011), and none has been evaluated in the context of impact on children’s health.
We report here results from a randomized controlled trial to
evaluate interventions targeting biomass smoke PM from oldermodel residential woodstoves in homes of children with asthma.
Older-model stoves are models deﬁned as not being certiﬁed by the
U.S. Environmental Protection Agency (EPA), or those that have
emissions of >4:1 grams=hour of PM for a catalytic stove or
7:5 grams=hour for a noncatalytic stove. The Asthma Randomized
Trial of Indoor Wood Smoke (ARTIS) took place in rural areas of
Montana, Idaho, and Alaska, where residential wood combustion is a
major source of ambient and indoor PM2:5 and the primary source of
home heating during cold-temperature periods. Our aims were to test
the hypothesis that (a) improved-technology wood-burning stoves or
(b) air-ﬁltration units would result in improvements, relative to placebo, in asthma measures among children in participating homes.

Methods
Study Overview
The ARTIS study design has been previously described (Noonan
and Ward 2012). Brieﬂy, ARTIS was a three-arm randomized
placebo-controlled intervention trial with two intervention strategies for reducing in-home woodsmoke PM (Figure 1). Eligible
participants were identiﬁed by parent-response screening questionnaire (Magzamen et al. 2005) and included children with
asthma, age 6–18 y, residing in a non-tobacco-smoking household that used an older-model woodstove as their primary
source of heating. If a household had more than one eligible
child with asthma, the child with more severe asthma based on
screening questions was designated as the primary participant in
the household, but all eligible, consented children with asthma
were included in the analyses. Overall, ARTIS was conducted
over ﬁve years. Each household participated in two consecutive
winter periods with household interventions occurring between
the two winter periods (Figure 2). Homes were randomly
assigned to one of three treatments: the woodstove-intervention
group receiving improved-technology wood-burning appliances
(i.e., EPA-certiﬁed woodstoves), the air-ﬁlter group receiving
functioning air-ﬁltration devices, and the placebo group receiving

Figure 1. Trial proﬁle. Note: The woodstove changeout arm (W) was discontinued prior to recruiting the ﬁnal cohort of homes.
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Figure 2. Study locations according to years of participation. Note: The
woodstove changeout arm (W) was discontinued prior to recruiting the
ﬁnal cohort of homes. F, air ﬁlter arm; W, woodstove changeout arm; P,
placebo arm.

sham air-ﬁltration devices. Detailed speciﬁcations of the intervention treatments can be found in Supplemental Material. This study
was approved by the University of Montana Institutional Review
Board. Participating children completed documented assent procedures, and a parent or guardian signed parental permission forms.

Health Measures
The primary health outcome was change in the score on the
Pediatric Asthma Quality of Life Questionnaire (PAQLQ) administered directly to children at each visit. The PAQLQ is a 23-item
asthma-speciﬁc battery that provides an overall score as well as
domain scores for symptoms (10 items), activity limitation (5
items), and emotional function (8 items) (Juniper et al. 1996).
The instrument requires the participating children to reﬂect on
the experiences over the prior week; thus, it is a one-week retrospective self-assessment (Figure 3). This instrument has strong
correlation, both longitudinal and cross-sectional, with other
measures of asthma severity, such as peak ﬂow monitoring, medication use, and symptom diaries, among children with asthma
ages 7 through 17 y (Juniper et al. 1996). The score for each domain is the average of the items in it, with scores ranging from 1
to 7 (with 7 as the optimal score), and the overall PAQLQ score
was the mean score across the three domains. The primary hypothesis was that the preintervention to postintervention change
in PAQLQ scores would be greater in the woodstove changeout
or air ﬁlter arms relative to placebo. Our a priori power estimates
indicated that when comparing two groups, a sample size of 30
subjects per group would provide 80% power to demonstrate a
diﬀerence in PAQLQ scores of 1.0 unit or greater at the 95% conﬁdence level (CI).

Figure 3. Schematic of sampling visit. Each visit occurred multiple times
during each of two winter periods, a preintervention winter and a postintervention winter. For a given visit, study personnel administered the PAQLQ
to participants. The PAQLQ is a self-assessment questionnaire reﬂecting on
the child’s past week of experiences. At the sampling visit, children are
trained in the use of the expiratory ﬂow monitor and begin recording twicedaily measures of PEF and FEV1 for two weeks. Indoor air monitoring was
initiated on Day 0 and continued for 48 h. Note: FEV1 , forced expiratory
volume in the 1st second; PAQLQ, pediatric asthma quality of life questionnaire; PEF, peak expiratory ﬂow.
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Secondary outcomes included home-based peak ﬂow monitoring. Parents and children were trained to collect twice-daily
measures (in the morning and in the evening) of peak expiratory
ﬂow (PEF) and forced expiratory volume in the ﬁrst second
(FEV1 ) using the PiKo-1 Peak Flow Meter (Ferraris). These
measures were collected and logged during a two-week period
beginning with the ﬁrst day of an exposure sampling visit. For
each measure, the child performed a peak ﬂow maneuver three
times, and the device stored the best result for PEF and FEV1 .
Outcomes from these two-week recordings included average percent predicted morning PEF and FEV1 , average percent predicted
evening PEF and FEV1 , and average diurnal PEF variability
(dPFV). Daily dPFV was the amplitude as a percentage of the
mean of consecutive evening to morning readings, or (previous
night PEF–morning PEF)/(mean of the two measures) (Lebowitz
et al. 1997). Whereas lower percent predicted PEF and FEV1 are
considered worse outcomes, the opposite is true for dPFV, where
higher dPFV is considered a worse outcome for children with
asthma.
Additional child data were collected to characterize baseline
health. During each two-week sampling period, parents of participating children were also asked to record daily health-related
events for their child, including daytime cough or wheezing,
nighttime cough or wheezing, activity limitations due to asthma
symptoms, and use of asthma medications. These data together
with peak-ﬂow monitoring data collected during the baseline
(preintervention) winter were used to classify asthma severity
based on the 2007 National Heart Lung and Blood Institute
(NHLBI) guidelines (National Heart Lung and Blood Institute
2007). For methods used to translate these data to the 2007
NHLBI asthma severity classiﬁcations and for overall severity
classiﬁcation of participants and severity classiﬁcation according
to speciﬁc components, see Supplemental Material and Table S1.

Exposure Assessment
The exposure and health assessments took place on two, 48-h observation periods during each of two winter periods, before and
after intervention. A DustTrak® Aerosol Monitor 8520/8530
(TSI) was used to continuously measure PM2:5 concentrations
that were corrected for woodsmoke (McNamara et al. 2011). A
Lighthouse 3016-IAQ particle counter (Lighthouse Worldwide
Solutions) was used to continuously measure particle number
concentrations of varying size fractions (0.30–0.49, 0.50–0.99,
1.00–2.49, 2.5–5.0, and 5.0–10.0, 10:0 + lm). Particle number
concentrations (PNCs), reported as the number of particles per
cubic centimeter, were summed across the size fractions
2:5–10:0 lm and were used as a surrogate for concentrations of
coarse PM (PMc). Samplers had 60-s recording intervals, and
were zero calibrated prior to each sampling event. We
included only those 48-h averages that were generated from
data that were at least 80% complete to ensure that the averages were representative of concentrations experienced during
the entire sampling events. Instrument malfunctions (e.g., ﬂow
errors) or power failures were the primary reasons for sampling events with less than 100% air-sampling data capture.
Prior to sampling, participants completed demographics and
home characteristics surveys. These surveys documented information such as household income, education, type/age/size of
home, age of woodstove and speciﬁc activities that occurred in
the home during the 48-h sampling periods.

Statistical Analysis
We used analysis of variance or chi-square tests, as appropriate,
to compare diﬀerences between treatment groups in descriptive
Environmental Health Perspectives

characteristics such as age, sex, race/ethnicity, and baseline
health measures. We followed the principle of intent-to-treat and
included all participants who were randomized to a treatment arm
and had at least one baseline measure. The objective of our statistical analysis was to evaluate whether intervention assignment
modiﬁed the preintervention-to-postintervention winter change in
PAQLQ or peak ﬂow measure. As such, the linear mixed eﬀects
model included ﬁxed eﬀects for a) winter (i.e., preintervention or
postintervention winter), b) intervention assignment (e.g., air ﬁlter), and c) a multiplicative interaction term between these two
variables to assess eﬀect modiﬁcation by intervention assignment. These models also included ﬁxed eﬀects for age and gender. Initially, random eﬀects were included for both the intercept
and the slope (i.e., winter), which in eﬀect allowed each participant to have his or her own intercept and slope describing change
in asthma measure from the preintervention to postintervention
winter. However, there were problems with estimation of the
model when we included a random eﬀect for the slope (i.e., winter). As a result, our ﬁnal model included a random eﬀect only
for the intercept. Winters were nested within participants, and
participants were nested within homes. The linear mixed-model
analysis amounts to adopting likelihood-based available-case
analysis for handling missing data. In post-hoc sensitivity analyses, we examined the impact on results when we adjusted for
additional covariates, including baseline asthma measures, use of
asthma medications, and ambient temperature because these factors could inﬂuence both the use of the woodstove and asthma
measures. We also performed separate analyses for each level of
baseline asthma severity. All intent-to-treat analyses were conducted using SAS (version 9.3; SAS Institute Inc.).
The interventions utilized in this study were designed to
improve various measures of childhood asthma by improving
indoor air quality. Speciﬁcally, the objective was to lower concentrations of PM2:5 in homes. To assess the extent to which PM
reductions contributed to intervention eﬃcacy, we added both
natural log-transformed PM2:5 and coarse PM as time-dependent
variables to our primary models and examined potential attenuation of eﬃcacy of the interventions. In addition, to examine further whether impacts on health were consistent with changes in
PM, we used linear mixed models to assess the eﬀect of PM2:5
concentrations on PAQLQ scores and peak ﬂow measures. These
post-hoc analyses were no longer based on a randomized design
and were adjusted for treatment assignment, gender, and age.
PM2:5 concentrations were skewed and were natural logtransformed. Thus, results are presented as the change in PAQLQ
or peak ﬂow measure associated with a doubling of PM2:5 .

Results
Almost 7,000 recruitment surveys were administered and followup contact with the 408 potentially eligible households resulted
in 115 recruited children with asthma living in 98 eligible households (Figure 1). Insuﬃcient baseline data were collected for one
participant to classify according to asthma severity, and they
were not included in further analysis. Among the 114 remaining
participants, health and exposure data were captured at 422 overall visits (226 during the preintervention winter and 196 during
the postintervention winter). Prior to enrollment of the ﬁnal
cohort of homes, the woodstove intervention arm was discontinued as interim analyses indicated that the woodstove change-out
was not eﬃcacious in reducing indoor PM2:5 (Ward et al. 2017).
Thus, the sample size in the air ﬁlter and placebo arms were
approximately twice that of the woodstove arm.
Descriptive and baseline health characteristics by assigned
treatment arm are shown in Table 1. The overall mean [standard
deviation (SD)] age was 12.4 y (3.0), and 48.3% of participants
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Table 1. Baseline participant and household characteristics.
Participant characteristics

Woodstove changeout
(n = 22)

Air filter
(n = 46)

Placebo
(n = 46)

12.3 (3.1)
67.6 (28.4)
10 (45.5)

12.7 (3.3)
69.7 (27.5)
25 (54.5)

12.2 (2.5)
62.4 (30.1)
20 (43.5)

0 (0.0)
16 (76.2)
5 (23.8)
20 (95.2)
12 (57)
15 (75)
17 (77)

4 (9.8)
32 (78.1)
5 (12.2)
39 (95.1)
20 (50)
29 (74)
39 (85)

0 (0.0)
40 (88.9)
5 (11.1)
43 (95.6)
28 (62)
31 (69)
41 (89)

2 (9.1)
20 (90.9)

5 (10.9)
41 (89.1)

6 (13.0)
40 (87.0)

5.1 (1.0)
4.9 (1.2)
4.6 (1.3)
5.7 (0.8)

5.4 (1.0)
5.3 (1.0)
5.0 (1.1)
5.6 (1.1)

5.4 (1.0)
5.3 (1.1)
5.0 (1.3)
5.7 (1.0)

75.3 (19.0)
73.1 (19.4)
72.4 (25.8)
70.8 (25.6)
18.5 (8.5)

87.2 (18.1)
86.2 (18.2)
84.9 (24.7)
82.3 (22.8)
17.0 (10.4)

88.3 (24.9)
87.5 (24.4)
85.1 (21.9)
82.9 (23.0)
14.4 (6.3)

5.7 (3.8)
1.9 (2.9)

4.3 (3.2)
1.0 (1.5)

4.2 (3.1)
0.9 (1.6)

3.2 (3.0)
2.9 (4.6)

2.6 (2.7)
0.8 (1.4)

3.3 (3.0)
0.9 (1.6)

3.8 (2.9)
1.3 (1.9)

2.0 (2.3)
0.8 (1.4)

2.1 (2.4)
1.0 (2.4)

4.4 (6.2)
4.9 (7.1)

7.5 (10.6)
4.1 (7.9)

4.0 (7.4)
3.8 (6.4)

Age, mean years (SD)
Body mass index percentile, mean (SD)
Female sex, n (%)
Race, n (%)a
American Indian/Alaskan Native
White
Other
Non-Hispanic ethnicity, n (%)a
Household income ≥$40,000, n (%)a
Household post-secondary education, n (%)a
Dogs or cats in home, n (%)
Baseline (preintervention) Health Measures
Asthma Severity, n (%)
Intermittent or Mild
Moderate or Severe
PAQLQ, mean (SD)
Overall
Symptoms
Limitation of Activity
Emotion
Two-week spirometry monitoring, mean (SD)
Evening FEV1 percent predicted
Morning FEV1 percent predicted
Evening PEF percent predicted
Morning PEF percent predicted
Diurnal PEF variability (dPFV), %
Two-week reporting of symptoms and medical usage
Daytime cough/wheezing, days
Mild
Moderate/Severe
Nighttime cough/wheezing, days
Mild
Moderate/Severe
Altered activity/behavior, days
Mild
Moderate/Severe
Medication usage, doses
Long-term control medications
Quick relief medications

Note: FEV1 , forced expiratory volume in the first second; PAQLQ, pediatric asthma quality of life; PEF, peak expiratory flow.
a
Race/ethnicity, household income, and household education not reported for 7, 8, and 10 participant parents, respectively.

were female. Age, gender, and body mass index were similar
across treatment arms. Most participants were white (82%) and
non-Hispanic (95%), but race and ethnicity were not reported by
parents for seven children. Among those with available race data,
4 of the 41 participants assigned to the air-ﬁlter arm were
American Indian/Alaskan Native (AI/AN), and no participants
reported being of AI/AN race in the other two arms. In addition,
101 of the 114 participants (89%) were classiﬁed as having
moderate to severe persistent asthma (Table 1 and Table S1). A
majority of caregivers (57%) reported household incomes greater
than $40,000 per year, and 72% reported having some postsecondary education. The majority of homes (87%) reported having a
dog or cat. These factors were similar by treatment arm assignment. During the preintervention winter, overall median PM2:5
concentrations were 17:5 lg=m3 , and were higher, relative to placebo, in homes assigned to the woodstove changeout arm of the
trial. Median PMc was 0.32 particles per cm3 and similar in all
treatment arms.
Among the baseline health measures, averaged over preintervention winter sampling visits, asthma severity and PAQLQ did
not diﬀer among the treatment arms (Table 1). Children in the
woodstove changeout arm had a slightly higher proportion of participants experiencing moderate to severe asthma and lower
mean PAQLQ scores. FEV1 and PEF percent predicted were also
lower among participants in the woodstove changeout arm in
Environmental Health Perspectives

comparison with the other study arms. Mean (SD) dPFV during
the preintervention winter was 16.3% (11.1) across treatment
arms.
Within each arm, preintervention to postintervention changes
for PAQLQ and spirometry measures are presented in Table 2.
For all treatment arms, the overall PAQLQ composite score, as
well as domain scores for symptoms, activity limitation, and emotion, increased in magnitude by 0.2–0.7 on the seven-point scale
from one winter to the next. For the spirometry measures,
increases in FEV1 and PEF percent predicted measures would
indicate improvement in lung function, whereas decreases in
dPFV would also indicate improvement in lung function. In general, FEV1 and PEF percent predicted measures decreased (i.e.,
worsened) from preintervention to postintervention winters in both
the air-ﬁlter and placebo arms. In contrast, dPFV change in the
air-ﬁlter arm showed decreased variation, suggesting improved
function with a percentage point change of −2:0 (95%
ðCIÞ = − 4:7 to 0.7), or a 11.8% (95% CI: 27% to −4%) improvement in comparison with baseline in this arm.
Eﬃcacy analyses of preintervention to postintervention changes
in PAQLQ and spirometry measures for treatment arms relative
to placebo are presented in Table 2. Relative to the placebo arm,
the air-ﬁlter intervention and the woodstove changeout showed
no improvement in PAQLQ composite or domain scores. Mean
change in PEF and FEV1 were generally better for the air-ﬁlter
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Table 2. Preintervention to postintervention mean changes [95% confidence interval (CI)]a within arm and within intervention, relative to placebo (n = 114
participants).

Outcome

Observations

PAQLQ
Overall
Symptoms
Limitation of Activity
Emotion
Two-week spirometry monitoring
Evening FEV1 % predicted
Morning FEV1 % predicted
Evening PEF % predicted
Morning PEF % predicted
Diurnal PEF variability, %

422
422
422
422
406
408
407
409
404

Within group change
Woodstove
changeout
Air filter
0.47 (0.04, 0.90)
0.61 (0.13, 1.1)
0.61 (0.09, 1.1)
0.18 (−0:25, 0.61)
−0:09 (−8:7, 8.5)
0.96 (−7:8, 9.8)
0.07 (−7:9, 8.0)
1.1 (−6:9, 9.2)
−0:8 (−4:7, 3.0)

Placebo

Change relative to placebo
Woodstove
changeout
Air Filter

0.22 (−0:07, 0.52)
0.19 (−0:14, 0.52)
0.23 (−0:12, 0.59)
0.24 (−0:06, 0.53)

0.29 (0.01, 0.58)
0.18 (−0:33, 0.69)
0.23 (−0:09, 0.55)
0.38 (−0:19, 0.95)
0.48 (0.13, 0.82)
0.13 (−0:48, 0.74)
0.28 (−0:01, 0.56) −0:10 (−0:61, 0.41)

−0:07 (−0:47, 0.34)
−0:04 (−0:49, 0.41)
−0:24 (−0:73, 0.24)
−0:04 (−0:44, 0.36)

−2:7 (−8:7, 3.1)
−3:4 (−9:4, 2.7)
−4:6 (−10, 0.98)
−3:3 (−8:9, 2.3)
−2:0 (−4:7, 0.7)

−3:0 (−8:7, 2.6)
−2:6 (−8:4, 3.1)
−7:0 (−12, −1:7)
−6:7 (−12, −1:4)
2.2 (−0:4, 4.7)

0.24 (−7:8, 8.3)
−0:71 (−8:9, 7.5)
2.4 (−5:0, 9.9)
3.4 (−4:1, 11)
−4:1 (−7:8, −0:4)

2.9 (−7:3, 13)
3.6 (−6:8, 14)
7.1 (−2:3, 16)
7.8 (−1:6, 17)
−3:0 (−7:6, 1.6)

Note: FEV1 , forced expiratory volume in the first second; PAQLQ, pediatric asthma quality of life; PEF, peak expiratory flow.
a
Adjusted for age and gender.

and woodstove changeout arms, in comparison with the placebo
arm. For example, change (and 95% CI), relative to placebo, in
morning percent predicted PEF were 3.4 (−4:1 to 11) and 7.8
(−1:6 to 17) for air-ﬁlter and woodstove changeout arms, respectively. Observations for dPFV showed lesser variability for the
air-ﬁlter arm, with a 4.1 percentage point greater reduction in
dPFV (95% CI = − 7:8 to −0:4) from the preintervention to postintervention winters for the air-ﬁlter arm, relative to the placebo
arm, suggesting improved airway function (Table 2). The woodstove changeout arm showed a 3.0 percentage point reduction for
dPFV relative to placebo (95% CI = − 7:6 to 1.6).
To further evaluate the inﬂuence of asthma severity status on
intervention eﬃcacy, we conducted stratiﬁed analysis for intervention changes to dPFV according to baseline asthma severity
(Table 3). The highest point estimate for reduction in dPFV
among the air-ﬁlter group was observed among the children with
indications of severe asthma at baseline, but no diﬀerential eﬀect
in dPFV was evident when stratifying by severe or moderate
asthma groups. When combining those children with severe and
moderate asthma at baseline, the change in dPFV among the airﬁlter group relative to placebo was similar to the primary analysis
(−4:6; 95% CI: −8:6 to −0:5). When including only primary participants, or the child in a given home with the more severe
asthma symptoms, the change in dPFV among the air-ﬁlter group
relative to placebo was lower (−3:2; 95% CI: −7:2 to 0.80; see
Table S3). Additional sensitivity analyses, adjusting for baseline
health measure and/or ambient temperature, did not change the
eﬀect estimates appreciably (see Table S2).
As shown previously, we observed a strong overall reduction
in indoor PM2:5 concentrations (−67%; 95% CI: −77% to
−50%) for the air-ﬁlter group relative to the placebo group, but
we observed no overall change to indoor PM2:5 for the woodstove
exchange (0.0%; 95% CI: −40%, 65%), relative to the placebo
group (Ward et al. 2017). Figure 4 shows a smoothed distribution
of log-transformed PM2:5 measures, indicating strong overlap in
preintervention and postintervention observations. Distributions
of preintervention and postintervention PM2:5 measures for the
woodstove exchange and the placebo arms were similar, consistent with the previously reported ﬁndings of no change for each of
these arms. We observed strong reductions in PMc in both the ﬁlter (72%) and placebo (57%) intervention arms (Ward et al.
2017).
To further explore these changes to indoor air quality and
impact on health outcomes, we conducted post hoc analyses.
Inclusion of PM2:5 and PMc in our primary models attenuated the
estimate of the eﬃcacy of the air ﬁlter in improving dPFV, relative to placebo (Table 4). Intervention assignment continued to
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be unassociated with overall PAQLQ or the PAQLQ domain
scores when PM measures were included in analyses. However,
despite having no indication of eﬃcacy for air-ﬁlter interventions
on PAQLQ, our exposure response analysis did indicate that
PAQLQ was associated with PM2:5 (Table 5). Because PM
measures were natural log-transformed, we report changes in each
response variable associated with a doubling of PM exposure. A
doubling of PM2:5 concentration was associated with small
declines in overall PAQLQ [−0:09 (95% CI: −0:16, −0:02)] and
emotion domain [−0:10 (95% CI: −0:18, −0:03)] scores. PM2:5
was not associated with changes in most of our assessed spirometry measures. However, consistent with our intent-to-treat analysis,
a doubling PM2:5 was associated with increased (i.e., worsening)
dPFV, 0.64 (95% CI: −0:05, 1.34).

Discussion
To our knowledge, this investigation is the ﬁrst randomized controlled trial aimed at improving asthma symptoms in children by
reducing indoor PM2:5 concentrations generated from woodstoves used for heating. Although the ﬁlter intervention resulted
in the anticipated reductions in indoor PM2:5 concentrations, we
did not observe treatment eﬃcacy according to PAQLQ, our primary health outcome measure (Table 2). Given that this was a
subjective metric measured over a two-winter period, it is possible that there was a learning eﬀect due to repeated assessment.
Indeed, we observed an improvement in the magnitude of overall
PAQLQ score from the preintervention to postintervention winters in all treatment arms. Improvements also were observed in
the symptom and activity limitation PAQLQ domains for the
woodstove changeout arm and in the activity limitation PAQLQ
domains for the placebo arm (Table 2). As in analyses of the
overall PAQLQ score, no treatment eﬀect with respect to placebo
was observed for these domains. The preintervention to postintervention changes in PAQLQ were modest across all treatment
arms with most point estimate changes less than one-half unit,
whereas changes in this scale of 0.5 or more points have been
translated as a clinically relevant outcome (Juniper et al. 1996).
Assignment to the ﬁlter arm was associated with strong reductions in indoor PM2:5 concentrations in this randomized trial
(Ward et al. 2017). Reductions in coarse particles also were
observed in the ﬁlter arm and, unexpectedly, in the placebo arm.
This latter observation may explain, in part, why we did not demonstrate eﬃcacy for PAQLQ in the air-ﬁlter arm, relative to the
placebo arm. The mechanism for the observed improvement in
overall PAQLQ score, as well as in scores in the PAQLQ symptom and activity limitation domains, in the woodstove arm is
unclear. As demonstrated previously, homes assigned to this
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Table 3. Intervention effect on diurnal peak flow variability according to baseline asthma severity, relative to placebo, adjusted for age and gender.

All participants
Severe
Moderate
Intermittent/mild

Participant number
114
50
51
13

intervention experienced no improvement in PM2:5 concentrations
or PNCs of any size; they did experience reductions in carbon
monoxide concentrations, however (Ward et al. 2017).
Peak ﬂow measures were the secondary health measures for
this trial. We observed an improvement in dPFV, speciﬁcally a
4.1-percentage point reduction for children in the ﬁlter arm, relative to placebo. Of note, the ﬁlter arm had higher preintervention
dPFV, relative to the placebo, indicating the randomization was
not entirely successful in balancing asthma severity between
groups. Thus, we cannot rule out completely the possibility that
regression to the mean may explain, at least in part, the observed
eﬃcacy of the ﬁlter in improving dPFV. When analyses were
limited to only those with moderate or severe persistent asthma,
the improvement in dPFV variability was similar, perhaps even
stronger for those with severe asthma. Home-based peak ﬂow
monitoring is not well supported as a tool for clinical decision
making of asthma therapy (Kamps et al. 2001; Self et al. 2014;
Yoos et al. 2002). There also are questions about the validity of
dPFV as a clinical tool for asthmatic children, and correlation
between measures of peak expiratory ﬂow variation and
asthma symptoms may wane over longer periods of observation (i.e., >1 year), suggesting that this measure may be less
desirable as a tool for management of asthma in children
(Brand et al. 1999). Nonetheless, dPFV does track with hyperresponsiveness, severity of symptoms, unscheduled medical
visits, and response to bronchodilators (Brand et al. 1999;
Brouwer et al. 2006; Greenberg et al. 2012; Mortimer et al.
2001), and change in dPFV has been used as a measure that
reﬂects the dynamic nature of asthma (Lebowitz et al. 1997).
There is also support for using dPFV and similar measures
that reﬂect the natural diurnal variation of airway function and
response to exposures and treatments in randomized controlled
clinical trials (Frey and Bielicki 2017; Kaminsky et al. 2017).
Here we use dPFV in repeated two-week snapshots to indicate
short-term change and make no inferences regarding its utility

Figure 4. Kernal density plot of pre- (solid line) and postintervention
(dashed line) 48-h indoor ﬁne particulate matter (PM2:5 ) by treatment arm.
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Woodstove changeout
Mean change (95% CI)
−3:0 (−7:6, 1.6)
−1:4 (−9:3, 6.4)
−5:3 (−14, 3.3)
0.07 (−10, 10)

Observations
404
170
190
44

Air filter
Mean change (95% CI)
−4:1 (−7:8, −0:4)
−4:7 (−12, 2.6)
−3:8 (−9:2, 1.6)
−1:4 (−9:4, 10)

as a self-management tool. Increased dPFV has been shown to
correspond to bronchial responsiveness to nonspeciﬁc challenges (Cockcroft and Hargreave 1990; Hetzel and Clark
1980). More recently, dPFV among children with asthma was
positively associated with indoor measures of speciﬁc fungi
species (Bundy et al. 2009; Douwes et al. 2000).
Comparisons of PM and other air pollutant exposures with
dPFV among children with asthma are limited and have indicated
that pollutant eﬀects on dPFV may be stronger among children
with mild asthma. A study of children with mild asthma in Korea
showed that dPFV increased during Asian dust events in comparison with control days, with corresponding strong correlations
observed between PM10 concentrations and dPFV (Yoo et al.
2008). A panel study of children in France showed an association
between ambient SO2 and dPFV, but only among those children with mild asthma; no associations were observed for
ambient PM13 and dPFV (Segala et al. 1998). In contrast, the
present study supports an association between smaller size
fraction PM, speciﬁcally PM2:5 , and our ﬁndings of eﬃcacy
with respect to dPFV remained robust, perhaps stronger,
when limiting the analysis to children with moderate to
severe asthma. Our observed response in dPFV among children with moderate to severe asthma was consistent with
studies of medical intervention. Measures of PFV were found
to change favorably in response to treatment with inhaled
corticosteroids among children with moderate to severe
asthma (Simons 1997; van Essen-Zandvliet et al. 1992), but
not necessarily among children with mild asthma (Waalkens
et al. 1991).
The beneﬁcial impact of the air-ﬁlter intervention on dPFV
was not corroborated with parallel ﬁndings in other pulmonary
function measures, i.e., morning and evening percent predicted
FEV1 and PEF. The within-group improvement in dPFV following the air-ﬁlter intervention also was fairly small (i.e., 2 percentage point decline). Nevertheless, this change did indicate a
greater than 11% improvement in dPFV, relative to the baseline
winter mean in this group. Our exposure response analysis also
showed an association between elevated PM2:5 concentrations
and higher dPFV, consistent with our overall hypothesis that the
air-ﬁlter intervention improves health by improving air quality.
This study was relatively large, including more than 400 multiday exposure and health sampling visits among 114 children
with asthma from various rural regions in western Montana,
Idaho, and Alaska. Extensive information on air pollutant exposures, asthma measures, and relevant covariates was ascertained
with the randomized, placebo-controlled design providing protection against confounding. However, we note several limitations.
First, to the extent possible, participating ﬁlter and placebo homes
were blinded to their treatment assignment. This blinding was not
possible for the homes receiving the woodstove intervention.
Moreover, ﬁeld staﬀ responsible for collecting exposure and
health data were not blinded, as study protocol and eﬃcient use
of project resources required them to install intervention ﬁlter
units, replace ﬁlters at prespeciﬁed intervals, and collect homebased health and exposure data. Quality-control procedures
were employed to protect against any potential inﬂuence

097010-6

Table 4. Preintervention to postintervention mean changes (95% CI) for treatments relative to placebo, adjusted for age, gender and indoor particulate matter
(n = 114 participants).

Outcome

Adjusted for age, gender, PM2:5 a
Woodstove
changeout
Air filter

PAQLQ
Overall
0.18 (−0:34, 0.71)
Symptoms
0.38 (−0:20, 0.96)
Limitation of Activity
0.13 (−0:50, 0.75)
Emotion
−0:10 (−0:63, 0.44)
Two-week spirometry
monitoring
2.6 (−7:8, 13)
Evening FEV1 % predicted
3.2 (−7:4, 14)
Morning FEV1 % predicted
Evening PEF % predicted
6.9 (−2:7, 17)
Morning PEF % predicted
7.7 (−2:0, 17)
Diurnal PEF variability, %
−2:7 (−7:4, 2.0)

Adjusted for age, gender, PMcb
Woodstove
changeout
Air filter

Adjusted for age, gender, PM2:5 , PMcb
Woodstove
changeout
Air filter

−0:15 (−0:58, 0.27) 0.20 (−0:36, 0.77)
−0:13 (−0:60, 0.34) 0.39 (−0:23, 1.0)
−0:27 (−0:78, 0.24) 0.16 (−0:52, 0.83)
−0:14 (−0:57, 0.30) −0:06 (−0:64, 0.51)

−0:13 (−0:57, 0.32) 0.20 (−0:36, 0.77)
−0:11 (−0:60, 0.37) 0.38 (−0:23, 1.0)
−0:29 (−0:82, 0.24) 0.16 (−0:52, 0.83)
−0:08 (−0:53, 0.38) −0:06 (−0:64, 0.51)

−0:73 (−9:1, 7.7)
−1:7 (−10, 6.9)
0.62 (−7:4, 8.6)
1.7 (−6:3, 9.7)
−3:6 (−7:6, 0.4)

−0:51 (−9:3, 8.3)
−2:1 (−8:4, 4.2)
2.2 (−5:9, 10)
2.5 (−5:6, 11)
−3:2 (−7:4, 1.0)

1.3 (−10, 13)
2.2 (−9:2, 14)
6.3 (−4:0, 16)
7.1 (−3:1, 17)
−3:0 (−8:2, 2.3)

1.2 (−10, 13)
2.2 (−9:3, 14)
6.2 (−4:1, 17)
7.0 (−3:2, 17)
−3:0 (−8:3, 2.3)

−0:21 (−0:67, 0.24)
−0:20 (−0:70, 0.29)
−0:31 (−0:85, 0.24)
−0:19 (−0:66, 0.27)
−1:3 (−10, 7.8)
−2:4 (−11, 6.7)
1.2 (−7:2, 9.7)
1.8 (−6:6, 10)
−2:7 (−7:0, 1.7)

Note: FEV1 forces expiratory volume in first second; PAQLQ, Pediatric Asthma Quality of Life Questionnaire; PEF, peak expiratory flow.
a
Missing observations for models with PM2:5 : n = 5 for PAQLQ measures; n = 41 for spirometry measures.
b
Missing observations for models with PMc : n = 6 for PAQLQ measures; n = 38 for spirometry measures.

resulting from failures in blinding at the participant and investigator levels, but this circumstance remains a limitation when
considered in the context of rigorous randomized controlled
trial designs. Second, performance and recording of selfmonitored PEF and FEV1 measures is highly eﬀort dependent.
Our procedures included training participants and parents on
best-eﬀort procedures. Although within-individual variation in
eﬀort is likely, we expect that this error would be random rather
than systematic over the two-winter observation period, particularly when considering the most robust ﬁnding, change in
dPFV, where the smallest unit of measure is percent diﬀerence
in successive PEF measures in less than 24 h (i.e., evening to
morning). Third, despite the randomized design, we observed
higher preintervention PM2:5 concentrations and poorer baseline
health in participants residing in households assigned to the
woodstove changeout arm. This arm of the study was eliminated
early due to evidence of failed eﬃcacy with respect to reduction
of indoor PM2:5 concentrations. Had this arm continued to full
recruitment, it is possible that the baseline exposure and health
measures would have balanced with the other arms. This change
did result in larger numbers of participants allocated to the airﬁlter and placebo arms, making comparison between those arms
more robust. Nevertheless, observations for the woodstove
changeout arm relative to the placebo arm should be interpreted
with caution. Fourth, the nature of the intervention strategy being
tested in this study called for between-winter, rather than withinwinter, evaluations of preintervention-to-postintervention health
changes. Asthma health and response to environmental stimuli can
Table 5. Effects of doubling fine fraction particulate matter (PM2:5 ) concentrations on quality of life measures and two-week spirometry monitoring,
adjusting for age, gender, and intervention assignment.
Outcome
PAQLQ
Overall
Symptoms
Limitation of activity activity
Emotion
Spirometry
Evening FEV1
Morning FEV1
Evening PEF
Morning PEF
dPFV

Obs

Estimate

95% CI

415
415
415
415

−0:09
−0:08
−0:07
−0:10

(−0:16, −0:02)
(−0:16, 0.001)
(−0:16, 0.03)
(−0:18, −0:03)

398
400
399
401
396

0.55
0.43
0.02
−0:20
0.64

(−0:79, 1.88)
(−0:90, 1.77)
(−1:51, 1.55)
(−1:68, 1.28)
(−0:05, 1.34)

Note: dPFV, diurnal peak flow variability; FEV1 , forced expiratory volume in first second; Obs, observations; PAQLQ, pediatric asthma quality of life Questionnaire; PEF,
peak expiratory flow.
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change during a one-year period, particularly among adolescents
who typically have worsening symptoms during these ages. Given
the randomized design, we expect that such intra-individual
changes would not be diﬀerential with respect to treatment arm. A
crossover design was not possible in this study due to the woodstove changeout arm, but this approach may have been a more robust approach for evaluating within-winter ﬁlter versus placebo
eﬀects for children with asthma. Fifth, the eﬃcacy of the air-ﬁlter
intervention depended on the home residents operating the unit at
the recommended setting. To assess compliance, we measured
energy usage with Kilowatt meters attached at the ﬁlter units. As
demonstrated previously, mean percent compliance (i.e., actual
Kilowatt usage as a proportion of predicated Kilowatt usage) was
78%, and PM2:5 exposure reduction was robust to lower levels of
compliance (Ward et al. 2017). Sixth, although we conducted a
limited number of primary analyses, we performed nine primary
statistical tests and might observe an association due to chance
alone. As a result, we cannot rule out the possibility that the eﬃcacy of the air ﬁlter in improving dPFV is simply due to chance.
Finally, unlike patient-level clinical trials where compliant delivery of a drug or procedure accounts for 100% of the intended dose,
we must recognize that environmental intervention studies account
for some component of dose. Thus, despite substantial reductions
in indoor PM2:5 concentration following the introduction of the ﬁlter, participating children were still exposed to measurable PM2:5 .

Conclusions
Biomass combustion during residential heating is an important
source of household air pollution, particularly in rural communities, and evidence-based strategies to improve indoor air quality
and asthma outcomes in such settings are needed. This randomized trial targeted a vulnerable population, children with asthma
who were chronically exposed to woodsmoke. The interventions
tested did not result in improvements to quality-of-life measures,
but the air-ﬁltration device, a simple in-home intervention, was
eﬃcacious for improving the secondary measure dPFV, an indirect measure of airway hyper-responsiveness. The attenuation of
the eﬀect when including PM in the models as well as the
exposure–response analysis provide evidence that ﬁlter-based
PM reductions contribute, at least partially, to the observed
improvements in the dPFV. This trial was conducted across several rural communities in three states, but translation of these
ﬁndings to other settings with similarly exposed child asthma
populations would require further study and inquiry into the
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challenges associated with dissemination of in-home PM reduction strategies.
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